Innovis Asset Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Innovis Asset Management’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-8,851	Closed	-$411K	–	186
2023 Q2	$411K	Buy	+8,851	New	+$306K	0.15%	85

Innovis Asset Management's DICE Position: Q3 2023 in Review

Innovis Asset Management sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 8,851 shares — an estimated $411K sold.

Innovis Asset Management first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $411K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Innovis Asset Management reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Innovis Asset Management sold 8,851 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $411K.
Innovis Asset Management first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Innovis Asset Management's DICE Therapeutics, Inc. Common Stock position peaked at $411K in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Innovis Asset Management's 13F filing for Q3 2023, filed 9 Nov 2023.